historical reports Flashcards
1
Q
when was the nuremberg code developed?
A
1947
2
Q
when was the declaration of helsinski adopted?
A
adopted by World Medical Association in 1964
3
Q
when was the belmont report signed into law?
A
1974
4
Q
when was the belmont report added to the US federal registar?
A
April 1979
5
Q
the FDA’s medical device amendments was developed in ___
A
1976
6
Q
___ and ____ claimed “dubious experiments have NO therapeutic purpose”
A
Stauder and Von Muller
7
Q
What are the 10 principles of the NUREMBERG CODE?
A
(V-F-A-U-D-R-P-Q-W-T)
(Vy-Finds-An-Ugly-Dumb-Round-Pug-Quietly-Walking-Today)
- voluntary consent
- experiment should be to yield fruitful results for the good of society, unprocurable by other methods and not random
- design was based on results of animal experimentation and must have a knowledge of the natural history of the disease
- avoid all unnecessary physical or mental suffering and/or injury
- should not be conducted if there is reason to believe that death or disablement will occur (unless physicians also serve as subjects)
- degree of risk should NOT exceed that of the problem
- proper preparations should be made and adequate facilities provided to protect subjects against even remote possibilities of injury, disability or death
- experiment should only be conducted by scientifically qualified persons
- subject should be able to bring experiment to the end if they have reached physical/mental state where continuing is impossible
- scientist in charge must be prepared to terminate experiment at any stage if they have cause to believe that continuing would likely result in injury, disability or death
8
Q
What are the 3 principles of the BELMONT REPORT?
A
- Respect for persons
- Beneficence
- Justice
9
Q
What topics do the DECLARATION OF HELSINSKI address?
A
(R-V-R-E-P-P-P-R-U-I)
(Rachel-Vy-Raced-Eliana-P-P-P-R-U-I)
- risks, burdens and benefits
- vulnerable populations
- scientific requirements and research protocols
- research ethics committees
- privacy and confidentiality
- placebo use
- post trial provisions
- research registration and publication and dissemination of results
- unproved interventions in clinical practice
- informed consent